OneMedNet Corp (ONMD): Nasdaq/NYSE listing notice — OneMedNet receives Nasdaq notice for minimum bid price non-compliance

OneMedNet Corp

Received Nasdaq notice on April 14, 2026 for failing $1.00 minimum bid price rule over 30 consecutive business days.
Has 180 calendar days, until October 12, 2026, to regain compliance by closing at $1.00+ for 10 consecutive business days.
May qualify for additional 180-day period if meets other listing standards and provides intent to cure, e.g., reverse stock split.
Company will monitor bid price and consider options, but no assurance of regaining compliance; failure could lead to delisting.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

OneMedNet Corp received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)

Exact text from the filing

April 14, 2026, OneMedNet Corporation (the “Company”) received notice (the “Notice”) from the staff of the Nasdaq Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company, based on the closing bid price of the Company’s common stock for the last 30 consecutive business days, is not in compliance with the $1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has a pe

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

OneMedNet Corp filing history →

Source: SEC EDGAR

accession 0001493152-26-018129

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.